Skip to main content
OpenTrials

Clinical trial condition

HER2-positive Breast Cancer

Explore clinical trials studying HER2-positive Breast Cancer. Study availability and eligibility vary by location and protocol.

202 public trials 83 recruiting studies
Refine in advanced search Browse all conditions

HER2-positive Breast Cancer trial results

Completed

FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors

NCT03841110

Conditions
Adenocarcinoma, Advanced Solid Tumors, Breast Diseases, +93 more
Locations
  • UCSD Moores Cancer Center San Diego, California, United States
  • University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States
  • Hackensack University Medical Center/John Theurer Cancer Center Hackensack, New Jersey, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Extension Study to Provide Adjuvant Treatment Following Neoadjuvant Treatment and Surgical Resection in Protocol TX05-03

NCT04109391

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • Tanvex Investigational Site 1006E Grodno, Belarus
  • Tanvex Investigational Site 1003E Homyel, Belarus
  • Tanvex Investigational Site 1008E Lesnoy, Belarus
  • Tanvex Investigational Site 1002E Minsk, Belarus
View all 86 locations
View Trial Details
Completed

Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer

NCT03556358

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations
  • Tanvex Investigational Site 1008 Lyasny, Minsk Oblast, Belarus
  • Tanvex Investigational Site 1007 Babruysk, Mogilyov Oblast, Belarus
  • Tanvex Investigational Site 1006 Grodno, Belarus
  • Tanvex Investigational Site 1003 Homyel, Belarus
View all 146 locations
View Trial Details
Completed

FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors

NCT03319459

Conditions
Adenocarcinoma, Advanced Solid Tumors, Breast Diseases, +63 more
Locations
  • UCSD Moores Cancer Center San Diego, California, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • The Ohio State University James Cancer Hospital Columbus, Ohio, United States
  • Baylor Scott & White Research Institute Dallas, Texas, United States
View Trial Details

Related conditions